# Amiodarone

## Amiodarone (Cordarone) inj 150mg/3mL

| TAH Drug Code      | [IAMIO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IAMIO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | For short-term use in the treatment of ventricular fibrillation， Wolff-Parkinson-White syndrome， supraventricular and ventricular tachycardia， atrial flutter and atrial fibrillation. For cardiopulmonary resuscitation during cardiac arrest associated with shock-resistant ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Must be administered using a volumetric infusion pump preferably via a central venous catheter. Initially 5 mg/kg in 250 mL of dextrose 5% IV infusion for 20 minutes to 2 hours. May repeat 2-3 times in 24 hours. Maintenance dose: 10-20 mg/kg (usually 600-800 mg/24 hours， maximum: 1.2 gm/24 hours) in 250 mL dextrose IV infusion. Cardiopulmonary resuscitation， Ventricular fibrillation/pulseless ventricular tachycardia: 300 mg IV by rapid infusion; a single dose of 150 mg IV may be repeated if Ventricular fibrillation/pulseless ventricular tachycardia recurs.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | - Patients with sinus bradycardia， sinoatrial heart block and not using an artificial pacemaker. - Patients with sinus node disease who are not using artificial pacemakers. (Risk of cardiac arrest) - Patients with high-grade atrioventricular block who are not using artificial pacemakers. - Bifascicular or trifascicular conduction disorders should not be used unless a functioning pacemaker is used. - Patients with thyroid dysfunction. - Known hypersensitivity to iodine or amiodarone or any of the excipient ingredients. - Circulatory shock. - Severe hypotension. - Severe respiratory failure， cardiomyopathy or heart failure (which may worsen). - Because this medicine contains benzyl alcohol， it is contraindicated in children under 3 years old. - Pregnancy - Lactating woman. - Concomitant use with other drugs that may induce torsades de pointes 　 1.Class Ia antiarrhythmic drugs (quinidine， hydroquinidine， disopyramide， etc.)， 　 2.Class III antiarrhythmic drugs (sotalol， dofetilide， ibutilide， etc.)， 　 3.Other drugs such as: bepridil， cisapride， diphemanil， erythromycin IV， mizolastine， moxifloxacin， spiramycin IV， vincamine IV， etc. . H 4.Sultopride.                                                                                                                           |
| Adverse Effects    | Common: Hypotension (Oral， less than 1%; IV， 15.6%)， Photodermatitis (2-24%)， Photosensitivity (3-10%)， Thyroid dysfunction， Constipation (4-9%)， Loss of appetite (4-9%)， Nausea (10-33%)， Vomiting (10-33%)， Increased liver enzymes， Abnormal gait (4-9%)， Coordination problem (4-9%)， Dizziness (4-9%)， Involuntary movement (4-9%)， Movement disorder (4-9%)， Paresthesia (4-9%)， Peripheral neuropathy， Corneal deposit， Microdeposits， Visual disturbance (4-9%)， Malaise and fatigue (4-9%) Serious: Bradyarrhythmia， Cardiac dysrhythmia， Congestive heart failure， High threshold for implanted defibrillator， Prolonged QT interval， Sinus arrest， Torsades de pointes (Less than 2%)， Vasculitis， Ventricular arrhythmia， Injection site extravasation， Stevens-Johnson syndrome， Toxic epidermal necrolysis， Hyperthyroidism (2%)， Hypothyroidism (Up to 10% .)， Thyroid cancer， Thyrotoxicosis， Thrombocytopenia， Hepatotoxicity， Anaphylaxis， Hypersensitivity reaction， Lupus erythematosus， Low back pain， acute， Rhabdomyolysis， Pseudotumor cerebri， Raised intracranial pressure， Blindness AND/OR vision impairment level， Optic neuritis， Toxic optic neuropathy， Renal impairment， Acute respiratory distress syndrome (2%)， Pulmonary fibrosis， Pulmonary toxicity (Up to 17%) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amiodarone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

## Cordarone 200mg

| TAH Drug Code      | [OAMIO](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OAMIO)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Wolff-Parkinson-white syndrome， superior ventricular and ventricular tachycardia， atrial flutter， atrial fibrillation， ventricular fibrillation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Initial dose: 600mg/day in divided doses for 8-10 days. Maintenance dose: dosage range from 100mg daily (200 mg every other day) to 400 mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | - Sinus bradycardia and sinoatrial heart block without a pacemaker; - Sinus disease without a pacemaker (risk of sinus node arrest); - High-grade atrioventricular conduction disorder without a pacemaker; - Thyroid function Abnormal， as amiodarone may worsen the condition; - Known hypersensitivity to iodine or amiodarone or any of the excipients; - Pregnancy; - Lactating women; - Concomitant use of drugs that may induce torsade de pointes: 1.Class Ia antiarrhythmic Incorrect drugs (quinidine， hydroquinidine， disopyramide). · 2.Class III antiarrhythmic drugs (sotalol， dofetilide， ibutilide). · 3. Other drugs such as bepridil， cisapride， diphemanil， erythromycin IV， mizolastine， moxifloxacin， spiramycin IV， vincamine IV (see Interactions). 4.sultopride.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Common: Hypotension (Oral， less than 1%; IV， 15.6%)， Photodermatitis (2-24%)， Photosensitivity (3-10%)， Thyroid dysfunction， Constipation (4-9%)， Loss of appetite (4-9%)， Nausea (10-33%)， Vomiting (10-33%)， Increased liver enzymes， Abnormal gait (4-9%)， Coordination problem (4-9%)， Dizziness (4-9%)， Involuntary movement (4-9%)， Movement disorder (4-9%)， Paresthesia (4-9%)， Peripheral neuropathy， Corneal deposit， Microdeposits， Visual disturbance (4-9%)， Malaise and fatigue (4-9%) Serious: Bradyarrhythmia， Cardiac dysrhythmia， Congestive heart failure， High threshold for implanted defibrillator， Prolonged QT interval， Sinus arrest， Torsades de pointes (Less than 2%)， Vasculitis， Ventricular arrhythmia， Injection site extravasation， Stevens-Johnson syndrome， Toxic epidermal necrolysis， Hyperthyroidism (2%)， Hypothyroidism (Up to 10% .)， Thyroid cancer， Thyrotoxicosis， Thrombocytopenia， Hepatotoxicity， Anaphylaxis， Hypersensitivity reaction， Lupus erythematosus， Low back pain， acute， Rhabdomyolysis， Pseudotumor cerebri， Raised intracranial pressure， Blindness AND/OR vision impairment level， Optic neuritis， Toxic optic neuropathy， Renal impairment， Acute respiratory distress syndrome (2%)， Pulmonary fibrosis， Pulmonary toxicity (Up to 17%) |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amiodarone-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

